Story Poster
Photo by Michael C. Johnson-USA TODAY Sports
Baylor Football

A Hornets' Nest Awaits Baylor in Lubbock

October 25, 2022
8,219

Another game finished, another Jekyll and Hyde performance by Baylor. Fortunately this time, the Bears were able to find their footing and finish Kansas off. After racing out to a 28-3 first half lead, the Bears had a terrific opportunity to bury the Jayhawks, but a series of mistakes to end the second quarter carried into the second half. What was once a blowout was now a one-score game with 6:29 remaining.

To continue reading, you must be a SicEm365 Premium subscriber.
Try Premium for $1
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial
Discussion from...

A Hornets' Nest Awaits Baylor in Lubbock

5,057 Views | 3 Replies | Last: 2 yr ago by IowaBear
MrGolfguy
User Profile
Private Message
Ignore User Stop Ignoring
How long do you want to ignore this user?
24 hours One week Permanently Cancel
11:03a, 10/25/22
No problem; the Bears are bringing a big can of Spectracide that shoots out 27 feet.
Well I ain't no greenhorn!!
Reply Quote
Pecos 45
User Profile
Private Message
Ignore User Stop Ignoring
How long do you want to ignore this user?
24 hours One week Permanently Cancel
11:33a, 10/25/22
Beware, Bears.
Tech is hard to beat at home, and they are getting better.
Plus their HC came to Tech from BU, so he may have some inside skinny on what we will be doing on D.
This will be a hard-fought game.
Buckle your chinstrap.
“If you have a job without aggravations, you don’t have a job.”
Malcolm Forbes
Reply Quote
1
IowaBear
User Profile
Private Message
Ignore User Stop Ignoring
How long do you want to ignore this user?
24 hours One week Permanently Cancel
11:36a, 10/25/22
Key like every road game is a fast start, if we can somehow jump ahead early and take the crowd out of it we have a shot
Reply Quote
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.